Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wild thyme extract, derived from the perennial herb *Thymus serpyllum*, is a botanical extract studied for its immunomodulatory, anti-inflammatory, antioxidant, and potential anticancer properties. In skincare, it is marketed under trade names like CinderellaCare, where it acts as a skin-brightening agent by inhibiting the motor protein kinesin, thereby disrupting melanin transport to the skin's surface. In dietary health, standardized preparations such as Finzelberg's 360GUT have been clinically evaluated for improving gastrointestinal symptoms, enhancing gut microbiome diversity (such as reducing the Firmicutes-to-Bacteroidetes ratio), and promoting short-chain fatty acid production. Preclinical research also suggests that wild thyme extract may induce apoptosis and suppress angiogenesis in breast cancer cells, potentially through the inhibition of DNA methyltransferase (DNMT) and histone deacetylase (HDAC) activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wild thyme extract.